Skip to main content

Advertisement

Fig. 4 | EJNMMI Research

Fig. 4

From: Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer

Fig. 4

a [18F]-JK-PSMA-7 PET/CT scans obtained at 20 min, 50 min, 110 min, and 140 min p.i. and corresponding values for the SUVmax, SUVpeak, and TBR of one suspicious lesion within the prostate fossa (arrow). b [18F]-JK-PSMA-7 PET/CT scans obtained at 80 min, 110 min, 170 min, and 200 min p.i. and corresponding values for the SUVmax, SUVpeak, and TBR of a suspicious retroperitoneal lymph node (arrow). Here, we have quantified the middle lymph node from a PSMA-positive lymph node chain

Back to article page